Home LiteratureArticle Details
PMID: 1929879 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor.

Archives of virology ·Vol. 120 ·No. 1-2 ·1991-00-00 ·Pages 71-81

Schätzl H, Gelderblom HR, Nitschko H, von der Helm K

Abstract

Newly developed substrate analogue peptidomimetics are able to inhibit the human immunodeficiency virus, HIV-1 proteinase at nanomolar concentration. In HIV infected cell culture they exhibit antiviral activity. We have analyzed the non-infectious HIV particles produced in chronically HIV infected cell culture in presence of one of these inhibitors. The total production of virus particles was not substantially reduced in drug treated cultures, compared to non-inhibited control cultures, but the infectivity of these virus particles was reduced about 100 fold. The processing of gag and gag-pol protein precursor was inhibited; only borderline activity of reverse transcriptase (RT) could be detected in these particles and they contained nonprocessed gag precursor protein. Thin section electron microscopy of inhibitor-treated, HIV-infected cells revealed reduced viral cytopathogenicity and both inhibition of particle assembly and incomplete maturation of the particles formed. The HIV particles produced in the presence of the proteinase inhibitor were studded with envelope glycoprotein knobs and often comprised multiple budding regions, but were morphologically immature.

MeSH Terms
Antiviral Agents/pharmacology Cell Line Dipeptides/pharmacology Gene Products, gag/metabolism HIV Protease Inhibitors HIV-1/drug effects,pathogenicity,ultrastructure Humans Protein Precursors/metabolism
Chemicals
Antiviral Agents Dipeptides Gene Products, gag HIV Protease Inhibitors Protein Precursors EMD 57464
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Schätzl H
Max-von-Pettenkofer-Institut, Universität München, Federal Republic of Germany.
Gelderblom H R
Nitschko H
von der Helm K
References (18)
18 references, click to expand
  1. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
    Proc Natl Acad Sci U S A. 1988 Sep;85(18):6612-6 PMID: 3045820
  2. Properties of avian retrovirus particles defective in viral protease.
    J Virol. 1990 Oct;64(10):5076-92 PMID: 1697912
  3. Rational design of peptide-based HIV proteinase inhibitors.
    Science. 1990 Apr 20;248(4953):358-61 PMID: 2183354
  4. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.
    J Virol. 1988 Nov;62(11):4393-7 PMID: 3050149
  5. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
    Virology. 1987 Jan;156(1):171-6 PMID: 3643678
  6. Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.
    Science. 1990 Aug 3;249(4968):527-33 PMID: 2200122
  7. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.
    FEBS Lett. 1989 Apr 24;247(2):349-52 PMID: 2469601
  8. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7472-6 PMID: 2217178
  9. Morphogenesis and morphology of HIV. Structure-function relations.
    Arch Virol. 1989;106(1-2):1-13 PMID: 2669684
  10. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.
    J Virol. 1989 Jun;63(6):2550-6 PMID: 2657099
  11. Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease.
    Cell. 1988 Jul 29;54(3):363-8 PMID: 3293801
  12. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
    Nature. 1990 Jan 4;343(6253):90-2 PMID: 1688646
  13. Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.
    EMBO J. 1988 Jun;7(6):1785-91 PMID: 3049075
  14. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Science. 1990 Jan 26;247(4941):454-6 PMID: 2405486
  15. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
    N Engl J Med. 1989 Dec 14;321(24):1621-5 PMID: 2586564
  16. Active human immunodeficiency virus protease is required for viral infectivity.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90 PMID: 3290901
  17. Plasma viremia in human immunodeficiency virus infection.
    N Engl J Med. 1989 Dec 14;321(24):1626-31 PMID: 2511447
  18. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.
    J Virol. 1990 Oct;64(10):5230-4 PMID: 2204725
Article Info
Journal
Archives of virology
Abbr.
Arch Virol
ISSN
0304-8608
Published
1991-00-00
Pages
71-81
Language
English
Region
Austria
NLM ID
7506870
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com